Sarepta Therapeutics | SRPT - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amgen USD 11.69B 2.5B 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Capricor Therapeutics USD 246.22M 32.48M 2026-06
Daiichi Sankyo JPY 1.7T 38.53B 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
Incyte USD 6.34B 721.58M 2026-06
Insmed USD 757.49M 52.64M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Moderna USD 6.76B 647M 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novavax USD -190.71M 45.94M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 69.57B 3.24B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06